States Fail Minimum Guidelines for Antitobacco Spending

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 3
Volume 11
Issue 3

WASHINGTON-Most states get a failing grade in the latest assessment of spending on antitobacco programs. The updated report on how the states are allocating the money they receive from legal settlements with the tobacco industry shows that only five states are providing funds for tobacco prevention programs at or above the lowest amounts recommended by the Centers for Disease Control and Prevention (CDC).

WASHINGTON—Most states get a failing grade in the latest assessment of spending on antitobacco programs. The updated report on how the states are allocating the money they receive from legal settlements with the tobacco industry shows that only five states are providing funds for tobacco prevention programs at or above the lowest amounts recommended by the Centers for Disease Control and Prevention (CDC).

CDC guidelines suggest a minimum spending level for each state that ranges from 20% to 25% of the settlement funds a state receives. Only Arizona, Maine, Massachusetts, Mississippi, and Minnesota meet or exceed the suggested minimum, according to the report released by the American Cancer Society, American Heart Association, Campaign for Tobacco-Free Kids, and American Lung Association.

The report also noted that some states have cut the percentage of settlement dollars devoted to tobacco programs because their revenue intakes have diminished as a result of the economic recession. Florida, for example, slashed funds for its highly regarded tobacco control efforts by 20% in December 2001. Tennessee legislators voted to spend all of the state’s settlement funds received thus far to balance its budget for 1 year.

Only 19 states have funded their tobacco programs at or above 50% of the recommended levels; only 16 provide funding at 25% to 50% of the minimum, and 12 support tobacco programs at less than 25% of the minimum. Michigan, North Carolina, Tennessee, and the District of Columbia have committed no major funding—either from their settlement money or other revenue sources —to tobacco prevention. 

Related Videos
Positive margin rates have not appeared to improve for patients with cancer undergoing surgical care based on several prior studies.
Investigators must continue to explore the space for lisocabtagene maraleucel in mantle cell lymphoma, according to Manali Kamdar, MD.
Those with CML should discuss adverse effects such as nausea or fatigue with their providers to help optimize their quality of life during treatment.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Patients with CML can become an active part of their treatment plan by discussing any questions that come to mind with their providers.
A panel of 4 experts on multiple myeloma
Video 1 - 4 KOLs are featured in "Treating Patients Referred to Academic Centers for CAR T"
Video 1 - 4 KOLs are featured in "Identifying Potential Candidates for CAR T-Cell Therapy"
Related Content